ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Gastrointestinal SPORE To Be Recompeted

June 23, 1995

For Frederick, Unseat Program Resources Inc.

March 3, 1995

NiH Conference: More Discord Than Consensus At Statement’s Presentation

January 31, 1997

Fewer Young Scientists win NIH Grants, Study

September 30, 1994

In Brief: Rhoads, Schmidt Bow Out – Amos, Krim Possible Replacements; Sibal acting Virology Director

January 27, 1978

NCI Continues Making Improvements In Contract Management

May 22, 1981